Scn8atm1.1Aesc
Targeted Allele Detail
|
Symbol: |
Scn8atm1.1Aesc |
Name: |
sodium channel, voltage-gated, type VIII, alpha; targeted mutation 1.1, Andrew Escayg |
MGI ID: |
MGI:5749693 |
Synonyms: |
Scn8a R1627H, Scn8aRH |
Gene: |
Scn8a Location: Chr15:100767739-100943819 bp, + strand Genetic Position: Chr15, 56.39 cM, cytoband F1
|
Alliance: |
Scn8atm1.1Aesc page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:228931
|
Parent Cell Line: |
Pat5 (ES Cell)
|
Strain of Origin: |
129X1/SvJ
|
|
Allele Type: |
|
Targeted |
Mutations: |
|
Insertion, Single point mutation
|
|
|
Mutation details: The targeting construct introduced a mutation that results in the amino acid substitution of histidine for arginine at position 1648 (R1648H) and two additional silent substitutions in exon 26. Flp-mediated recombination removed the neomycin resistance cassette.
(J:228931)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Scn8a Mutation: |
98 strains or lines available
|
|
Original: |
J:228931 Makinson CD, et al., An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. Exp Neurol. 2016 Jan;275 Pt 1:46-58 |
All: |
1 reference(s) |
|